New

ETF model portfolios designed for real investor needs. Discover →

Advertisement
Advertisement

XLVvsIYHETF Comparison

ETF 1
XLV

State Street Health Care Select Sector SPDR ETF

This fund is part of
US Health Care
-0.32%
VS
ETF 2
IYH

iShares U.S. Healthcare ETF

This fund is part of
US Health Care
-0.32%

State Street Health Care Select Sector SPDR ETF (XLV) and iShares U.S. Healthcare ETF (IYH) belong to the same industry segment: US Health Care. XLV's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, IYH's top sector exposures are Healthcare, Non-Corporate and Finance. XLV is less expensive with a Total Expense Ratio (TER) of 0.08%, versus 0.37% for IYH. XLV is up 17% year-to-date (YTD) with +$1.62B in YTD flows. IYH performs worse with 16.54% YTD performance, and +$360M in YTD flows. Run a side-by-side ETF comparison of XLV and IYH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XLV vs IYH performance and flow charts

Performance

-2.00.02.04.06.0%Sep 21Sep 28Oct 5Oct 12Oct 19

Cumulative Flows

-1,000 M-500 M0 M500 M1,000 MSep 21Sep 28Oct 5Oct 12Oct 19

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/21/2026
1M3MYTD1Y3Y5Y
Perf.
XLV
IYH
+5.88%+5.05%
+12.04%+11.83%
+17.00%+16.54%
+25.36%+24.54%
+47.72%+46.56%
+47.89%+40.49%
Flows
XLV
IYH
+$1.26B+$386M
+$871M+$982M
+$1.62B+$360M
+$2.34B+$818M
-$3.03B+$348M
+$4.98B+$576M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XLV
IYH
+17.46%+17.52%
+16.26%+16.39%
+14.96%+15.19%
+15.24%+15.50%
Max drawdown
XLV
IYH
-5.81%-5.88%
-10.51%-10.72%
-17.05%-17.89%
-17.05%-17.89%
Max drawdown duration
XLV
IYH
56d56d
116d169d
444d445d
444d445d
Trading data

Create an account to view trading data

Join for free
XLV
IYH
Last sale
10/22/2026 at 1:30 PM
$181.30
$76.22
Previous close
10/21/2026
$178.94
$75.22
Consolidated volume
10/21/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XLV
IYH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/22/2026 at 1:30 PM
Live
Closed
XLV
IYH
Last price
$181.30
$76.22
1D performance
+1.32%
+1.33%
AuM$47.46 B$4.48 B
E/R0.08%0.37%
Characteristics
XLV
IYH
Management strategyPassivePassive
ProviderState Street Investment ManagementiShares
BenchmarkS&P Health Care Select Sector IndexRussell 1000 Health Care RIC 22.5/45 Capped Gross Index
N° of holdings59101
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateDecember 16, 1998June 12, 2000
ESGNoNo
Advertisement
Exposure

Countries

XLV
USA
97.52%
Other
2.48%
IYH
USA
96.86%
Other
3.14%

Sectors

XLV
Healthcare
97.84%
Other
2.16%
IYH
Healthcare
99.79%
Other
0.21%
Advertisement

Diversification

XLV

Total weight of top 15 holdings out of 15

71.32%
IYH

Total weight of top 15 holdings out of 15

68.68%

Top 15 holdings

Data as of August 31, 2026
XLV
Eli Lilly & Co.
14.88%
Johnson & Johnson
10.41%
AbbVie, Inc.
7.37%
Merck & Co., Inc.
5.93%
UnitedHealth Group, Inc.
5.75%
Amgen, Inc.
3.77%
Thermo Fisher Scientific, Inc.
3.73%
Abbott Laboratories
3.13%
Gilead Sciences, Inc.
2.95%
Pfizer Inc.
2.64%
Vertex Pharmaceuticals, Inc.
2.25%
Bristol Myers Squibb Co.
2.22%
Danaher Corp.
2.19%
Intuitive Surgical, Inc.
2.17%
CVS Health Corp.
1.95%
IYH
Eli Lilly & Co.
14.45%
Johnson & Johnson
10.02%
AbbVie, Inc.
7.10%
Merck & Co., Inc.
5.72%
UnitedHealth Group, Inc.
5.50%
Amgen, Inc.
3.63%
Thermo Fisher Scientific, Inc.
3.59%
Abbott Laboratories
2.99%
Gilead Sciences, Inc.
2.84%
Pfizer Inc.
2.53%
Vertex Pharmaceuticals, Inc.
2.17%
Bristol Myers Squibb Co.
2.13%
Danaher Corp.
2.11%
Intuitive Surgical, Inc.
2.08%
Medtronic Plc
1.82%
Frequently asked questions about XLV and IYH

How have the XLV and IYH ETFs performed in 2026?

As of October 21, 2026, XLV is up 17% year-to-date (YTD), while IYH has returned 16.54%. That puts XLV better performer ahead so far this year.

Which ETF is attracting more investor money: XLV or IYH?

Year-to-date, the XLV ETF saw +$1.62B in flows, compared to +$360M for IYH.

Which ETF is more volatile: XLV or IYH?

Over the past year, XLV had a volatility of 16.26%, while IYH experienced 16.39%.

Which ETF is bigger: XLV or IYH?

As of October 21, 2026, XLV holds $47.46 B in assets under management (AUM), while IYH manages $4.48 B.

What sectors do the XLV and IYH ETFs invest in?

XLV leans toward sectors like Healthcare. Meanwhile, IYH focuses on Healthcare.

What are the top holdings of the XLV ETF and IYH ETF?

XLV top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. IYH holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: XLV or IYH?

XLV holds 59 securities with 71.32% of its assets in the top 15. IYH has 101 securities and a top 15 weight of 68.68%.

Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

With 1,790 new products launched by July 2026, choosing is harder than ever. Our Global ETF Survey 2026, built on 620 professional investors and allocators, shows how active, fixed income, options-based and thematic ETFs are reshaping fund selection.

Global ETF Survey 2026